Competition in the US pharmaceutical market swelled in recent years, with increasing generic penetration.
While such buying could indicate confidence in the business, investors should do a comprehensive evaluation before getting into the stock.
Delhi's Connaught Place is the 6th most expensive location in the world.
The FDA has stepped up its efforts to ensure drug safety in recent months.
Hit by the new drug pricing policy and regulatory interventions, growth rate of the Rs 72,069-crore Indian pharmaceutical market has slowed down to 9.8 per cent in 2013 as compared to 16.6 per cent in 2012, says a report.
Airtel acquired African telecom operator Zain in 2010 for $10.7 billion.
Over-expansion, bad management, and multiple allegations irreparably taint Malvinder and Shivinder Singh
On October 2, a legislature committee wrote letters to the 14 companies, initiating an investigation and seeking details about recent price increases in several generic products available in the American market.
Better-than-expected financial results in Q3 due to higher revenue growth and margins in key markets fuel the rally
The move assumes significance because a go-ahead from the US Food and Drug Administration for the new unit in Visakhapatnam is likely to give a huge boost to the company's revenues in upcoming quarters.
Once tipped to emerge as the biggest exporter, the pharmaceutical industry is yet to acquire the scale of those in software services, says Krishna Kant.
The India growth story is still intact, and fall in the Indian stock markets is an imported one and if the government succeeds in legislating the GST and Land Bill, India could yet emerge as a winner believe stock market experts
Import alert on Ranbaxy's Mohali unit; Strides' injectible arm gets warning letter
The rally in most of these stocks is partly attributed to impressive financial performance.
Analysts are eyeing bigger launches that will positively impact company's fortunes.
Many members of ministry panel give dissent note on clause; no clarity yet on whether it will apply to existing shares or new ones.
Index heavyweight RIL surged 3% to end above Rs 1,000 mark while IT majors were also the top gainers.
Natco Pharma, Wockhardt and Marksans have rallied between 50 and 70 per cent in the year till date.
The real challenge, says Subir Roy, is to go for something affordable whose quality is just right.
Ajit Mishra, Vice President, Research, Religare Broking, answers readers' stock market queries. Ajit will offer his unbiased views on a weekly basis
Ajit Mishra, Vice President, Research, Religare Broking, answers readers's queries on stocks they own or want to buy.
In a surprise announcement in April, Sun and Ranbaxy -- at that time owned by Japan's Daiichi -- declared an all-stock deal to create India's largest and world's fifth-largest drugmaker in an over $4 billion deal.
Ajit Mishra, Vice President, Research, Religare Broking, answers readers' stock market queries. Ajit will offer his unbiased views on a weekly basis
Inspections only in domestic authorities' presence, visiting US drug regulator told
The country's drug companies have attracted the highest number of enforcements from the American drug regulator in 2013, a year that has seen the US Food and Drug Administration turning stricter to ensure compliance levels and quality of medicines.
As record stock market rally continues, the value of shares directly owned by next-generation business leaders at 20 major corporate houses has soared over 18 per cent to Rs 17,000 crore.
Whistle-blower Dinesh Thakur will speak on Made-in-India drugs at an event in Washington.
As part of the charm offensive, New Delhi has invited global regulators -- including the FDA -- to visit Indian production units to get first-hand evidence of measures taken to ensure the quality of locally manufactured generics.
A probe finds several pharma majors in breach of the law; and in turn they blame the government.
Rediff.com presents some of the oddest Guinness world records held by Indians.
Data also show that several other leading domestic pharma companies have recalled their products from the US
Another year of strong performance by these export-oriented sectors likely as US economy revives and rupee is expected to be under pressure.
'Your constant reiteration on the lack of religious freedom in India has sown doubts about the kind of information that you are being fed and based on which you seem to be making adverse references to India and its tradition of religious tolerance.'
The former McKinsey India head is presently on board of many big Indian conglomerates.
Financial numbers can sometimes paint a rosy picture because of changes in the accounting policy or a one-time income.
'If one observes a common man passing a church or gurdwara or dargah, he instinctively bows his head. It is this prevalence of polytheism that has ensured that monotheists and minorities flourish in India. This may sound preposterous in wake of the recent communal clashes in Muzaffarnagar. But it must be understood that in a county of over one billion people that was at worst an aberration,' says Colonel Anil A Athale (retd).
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances